<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04369261</url>
  </required_header>
  <id_info>
    <org_study_id>LG-HAOS006</org_study_id>
    <nct_id>NCT04369261</nct_id>
  </id_info>
  <brief_title>Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee</brief_title>
  <official_title>A Multicenter, Prospective Observational Study to Evaluate the Injection Site Reactions of Synovian® Inj. in Patients With Osteoarthritis in the Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LG Chem</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LG Chem</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study to evaluate the injection site reactions of Synovian® Inj. in
      patients with osteoarthritis in the knee
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 9, 2018</start_date>
  <completion_date type="Actual">August 8, 2019</completion_date>
  <primary_completion_date type="Actual">August 8, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>safety endpoints</measure>
    <time_frame>Week 2</time_frame>
    <description>injection site reactions</description>
  </primary_outcome>
  <enrollment type="Actual">1949</enrollment>
  <condition>Osteoarthritis in the Knee</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Synovian®</intervention_name>
    <description>Synovian® Inj.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A patient from hospital and clinic as well
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male or female patient of over 19 years of age

          -  A patient diagnosed with knee osteoarthritis

          -  A patient who has been informed of the purpose, method of the study and signed the
             written informed consent form.

        Exclusion Criteria:

          -  A patient who shows hypersensitive reaction to the Synovian® Inj. or to the
             ingredients of Synovian® Inj.

          -  A patient with infection at the joint

          -  A patient with skin infection or skin disease at the injection area

          -  A patient diagnosed with osteoarthritis with the Kellgren &amp; Lawrence Grade IV in X-ray
             within 12 months before enrollment of this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hanyang University GURI Hospital</name>
      <address>
        <city>Guri-si</city>
        <state>Gyeonggi-do</state>
        <zip>11923</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 28, 2020</study_first_submitted>
  <study_first_submitted_qc>April 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2020</study_first_posted>
  <last_update_submitted>April 28, 2020</last_update_submitted>
  <last_update_submitted_qc>April 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>not decided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

